which one?
- Ryoncil BLA resubmission accepted by the FDA, with the 6 month review clock officially started
- CHF approval pathway clarified by the FDA, single trial approval pathway or second trial needed. With either pathway resulting in a CHF partnership ex-China later in the year.
- COVID 19 ARDS phase 3 trial funded and initiated by the NIH
- CLBP second phase 3 trial initiated
MSB Trading 2022, The TurnAround, page-368
-
- There are more pages in this discussion • 681 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.015(1.56%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | 99.5¢ | 97.0¢ | $971.0K | 989.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 42 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 64394 | 29 |
View Market Depth
| Last trade - 11.05am 22/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |